Health Idea Now
Thursday, 3 October 2019
Japan drug price reforms risk hurting investment: Bristol-Myers CEO
Japan's "overly restrictive" drug pricing policies risk diverting foreign direct investment to China and other markets, the chief executive of Bristol-Myers Squibb said on Thursday.
from Reuters: Health News https://ift.tt/2pCGkc5
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment